A Phase 1 study of BMS-986470 in healthy volunteers and sickle cell disease patients

Recruiting Phase 1,Phase 2 NCT06481306

Study Description

A study to evaluate the safety and effectiveness of an investigational drug (BMS-986470) in healthy volunteers and patients with sickle cell disease

Study Details

Registry ID:
NCT06481306
Conditions:
Anemia, Sickle Cell, Healthy Volunteers
Phase:
Phase 1,Phase 2
Target Enrollment:
224 participants
Start Date:
Age Range:
18–999 years
Healthy Volunteers:
No

Study Locations (51 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →